ARCHIVES

Also Von Eschenbach role in industry program raises new concerns of conflict of interest.

This article is from The Cancer Letter archive.

Vol. 31 No. 43 | November 23, 2005

Download PDF Visit The Full Archive

Related Articles

Tracor Lands Second Biggest NCI Contract-$6.6 Million To Manage Commercial Labs’ Portion Of Bioassay Program

April 19, 1974

Organ Site Program Fate On Line, Gets Review Next Week

November 20, 1981

NCI To Begin Study of Augmentation Mammoplasty This Fall

May 8, 1992

NCI subsidy of $2 million paid major expenses of rescheduled meeting.

April 15, 2005

Three Congressmen Back Straus Demand For Single Probe

August 28, 1981

Letter to the Editors: Burzynski Responds To FDA Release Of Annual Report Data

May 22, 1998